Apolipoprotein E4
1 paper
- Humans1
Funding
1 grant since 2023National Institute on AgingUS$2.3m
Latest
10 in 12 monthsJournal of Cerebral Blood Flow and Metabolism
EXPRESS: Rapamycin increases cerebral blood flow and modulates metabolic, inflammatory, and microbiome profiles in healthy middle-aged APOE4 carriers: a pilot single-arm trial
Non-randomised trial in 23 peopleRapamycin
AAIC 2025 Abstract
Accuracy of an Automated Plasma Apolipoprotein E4 Proteotyping Immunoassay for Determination of APOE Genotype
Cross-sectional study of 104 peopleBiomarkers
AAIC 2025 Abstract
Introduction of APP induces bioenergetic deficits within an aged humanized APOE risk model of Alzheimer's disease: An FDG‐PET analysis
Experiments in miceAPP
AAIC 2025 Abstract
Impact of Vascular Risk Burden and ApoE4 on Cognitive Impairment: Insights from a Non‐Demented Southeast Asian Population
Cohort study of 838 peopleCognitive impairment
AAIC 2025 Abstract
APOE‐specific Cognitive Effects of Levetiracetam in Mid‐Age Adults
Randomised trial in 58 peopleInterventions
AAIC 2025 Abstract
Interaction Between APOE ε4 Status and Age on Medial Temporal Lobe Structures in Hispanic/Latino Older Adults
Cross-sectional study of 187 peoplePopulations
AAIC 2025 Abstract
Association of bradycardia with longitudinal cognitive decline
Cohort study of 390 peoplePopulations
AAIC 2025 Abstract
Roles of APOE e4 in Modulating the Relationship of Non‐genetic Risk Factors with Dementia and Alzheimer’s disease: A System Review and Meta‐analysis of 170 Longitudinal Studies
Meta-analysis of observational studiesAll-cause dementia
AAIC 2025 Abstract
Does APOE4 genotype moderate the effects of multidomain exercise interventions in older individuals living with mild cognitive impairment?
Randomised trial in 67 peopleExercise